Xiangcai Co

Xiangcai Co Capital Intensity

The Capital Intensity Ratio of Xiangcai Co (600095.SS) as of Nov 5, 2026 is 1,828.63 %. In the previous year, Capital Intensity Ratio was 2,236.34 % — a change of -18.23% (lower).

Capital Intensity

1,828.63 %

YoY

-18.23%

Last updated:

Capital Intensity Ratio of Xiangcai Co is 2025 1,828.63 % . Capital Intensity Ratio of Xiangcai Co was 2024 2,236.34 % . It decreases by -18.23% lower compared to the previous year.

The Xiangcai Co Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2018
347.24 CNY
Jan 1, 2019
72.82 CNY
Jan 1, 2020
1,438.61 CNY
Jan 1, 2021
880.52 CNY
Jan 1, 2022
1,161.35 CNY
Jan 1, 2023
1,815.97 CNY
Jan 1, 2024
2,236.34 CNY
Jan 1, 2025
1,828.63 CNY
The Xiangcai Co Capital Intensity history
YEARCapital IntensityYoY
1,828.63 %-18.23%
2,236.34 %+23.15%
1,815.97 %+56.37%
1,161.35 %+31.89%
880.52 %-38.79%
1,438.61 %+1,875.57%
72.82 %-79.03%
347.24 %-33.06%
518.71 %+13.28%
457.90 %+0.90%
453.83 %+58.80%
285.80 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Xiangcai Co Stock analysis

What does Xiangcai Co do? Xiangcai Co., Ltd. generates revenue through multiple business segments including non-GMO soybean products processing, pharmaceuticals, waterproof membrane manufacturing, and industrial plants. The company produces soybean protein isolate, soybean tissue protein, and soybean nutritious food under its soybean deep processing division. Its pharmaceutical segment focuses on thymopeptide enteric-coated tablets and other immune system treatment drugs. The waterproof membrane business manufactures and sells polyethylene polypropylene fiber coils, load-bearing coils, and joint profiles. Real estate development and property management contribute to the company's revenue through residential and industrial real estate projects. The primary buyers for soybean deep processing products include food manufacturers and health supplement companies seeking non-GMO ingredients. Pharmaceutical customers consist of hospitals, pharmacies, and healthcare providers purchasing thymopeptide enteric-coated tablets for immune system treatments. Waterproof membrane products are sold to construction companies and building contractors for infrastructure and residential projects. Real estate clients are residential buyers and industrial tenants requiring property development and management services. Xiangcai Co., Ltd. serves distinct market segments: food and beverage manufacturers for soybean products, healthcare institutions for pharmaceuticals, construction firms for waterproofing solutions, and residential/industrial property occupants for real estate services. The company's product portfolio spans from raw material processing to end-user applications across these sectors, creating diversified revenue streams. Xiangcai Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Xiangcai Co stock

Capital Intensity Ratio of Xiangcai Co is 1,828.63 % in 2025.

Capital Intensity Ratio of Xiangcai Co changed from 2,236.34 % to 1,828.63 %, representing a -18.23% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio Xiangcai Co since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's Xiangcai Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Xiangcai Co

All Key Metrics — Xiangcai Co